(Q35663624)

English

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro

scientific article published on 5 December 2011

Statements

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro (English)
5 December 2011

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit